Ultrasound‑targeted microbubble destruction‑mediated miR‑205 enhances cisplatin cytotoxicity in prostate cancer cells

超声靶向微泡破坏介导的 miR-205 增强顺铂对前列腺癌细胞的细胞毒性

阅读:9
作者:Dingwen Qin, Haige Li, Honglin Xie

Abstract

MicroRNAs (miRNAs) are non‑coding ~20 nucleotides long sequences that function in the initiation and development of a number of cancers. Ultrasound‑targeted microbubble destruction (UTMD) is an effective method for microRNA delivery. The aim of the present study was to investigate the potential roles of UTMD‑mediated miRNA (miR)‑205 delivery in the development of prostate cancer (PCa). In the present study, miR‑205 expression was examined by reverse transcription‑quantitative polymerase chain reaction assay. miR‑205 mimics were transfected into PC‑3 cells using the UTMD method, and the PC‑3 cells were also treated with cisplatin. Cell proliferation, apoptosis, migration and invasion abilities were detected using Cell Counting kit‑8, flow cytometry, wound healing and Transwell assays, respectively. In addition, the protein expression levels of caspase‑9, cleaved‑caspase 9, cytochrome c (cytoc), epithelial (E)‑cadherin, matrix metalloproteinase‑9 (MMP‑9), phosphorylated (p)‑extracellular signal‑regulated kinase (ERK) and ERK were measured by western blot analysis. The results of the present study demonstrated that miR‑205 expression was low in human PCa cell lines compared with healthy cells and that UTMD‑mediated miR‑205 delivery inhibited PCa cell proliferation, migration and invasion, and promoted apoptosis modulated by cisplatin compared with UTMD‑mediated miR‑negative control group and miR‑205‑treated group. Furthermore, it was demonstrated that UTMD‑mediated miR‑205 transfection increased the expression of caspase‑9, cleaved‑caspase 9, cytochrome c and E‑cadherin, and decreased the expression of MMP‑9 and p‑ERK. Therefore, UTMD‑mediated miR‑205 delivery may be a promising method for the treatment of PCa.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。